Establishing Pediatric CNS Pharmacodynamic Measures as Tools to Enable Psychiatric Indications in Adolescents
This grant funds research to develop pharmacodynamic measures for pediatric CNS applications in psychiatric indications.
About this program
The grant focuses on establishing pharmacodynamic measures specifically for pediatric central nervous system (CNS) applications. It aims to enable the assessment and treatment of psychiatric conditions in adolescents by providing reliable tools for measuring drug effects. This research is crucial for improving mental health outcomes in young populations who are often underrepresented in clinical studies. The target beneficiaries of this grant include researchers and institutions dedicated to pediatric psychiatry and pharmacology. By developing these measures, the grant seeks to enhance the understanding of how psychiatric medications affect adolescents, ultimately leading to better treatment protocols and improved patient care. The initiative will involve collaboration among various stakeholders in the healthcare and research sectors to ensure comprehensive development and application of these tools.
Eligibility
Eligible applicants include research institutions, universities, and healthcare organizations focused on pediatric mental health.
Requirements
- Must conduct research related to pediatric CNS pharmacodynamics
- Must have a focus on psychiatric indications in adolescents